Associate Professor, Medical Research – Immunology
Christina Kousparou conducts basic research in cancer stem cells, translational research in haematologic and solid malignancies, PPMS, RRMS, SPMS, and clinical applications of AAV9-mediated gene replacements for rare disorders in Cypriot patients (SMA, RP, LA).
Research Summary
My initial drug development research revolved around antibody therapeutics for the intracellular delivery of cytotoxic agents to vascular and neoplastic tissues. All stem cell, animal work and Phase I work was executed at The Bank of Cyprus Oncology Centre and Imperial College London and funded through a series of grants from the European Union and The Research Promotion Foundation.
My Phase III/IV clinical research is in collaboration with Novartis, Imperial College and The Bank of Cyprus Oncology Centre. My work on stem cells and gene therapies, includes the AAV9-medicated treatment of the first two Cypriot children with SMA disease on the Island.
Education
• PhD, 2000, Antibody Engineering, Imperial College London, UK
• DIC, 2000, Biochemistry, Imperial College London, UK
• BSc, 1996, Genetics, Leicester University, UK
Contact Information
Email: [email protected]
Address:
European University Cyprus
6 Diogenous Street
Engomi 2404, Nicosia
Cyprus
Publications
https://scholar.google.com/citations?hl=en&user=h8-hog0AAAAJ&view_op=list_works&sortby=pubdate
